Le Lézard
Classified in: Ebola virus, Health
Subject: PDT

Clorox Healthcare Canada sets sights on helping to reduce hospital-borne infections and improve patient outcomes

TORONTO, Feb. 28, 2018 /CNW/ - Clorox Healthcare Canada's innovative array of disinfecting solutions are helping healthcare professionals in leading the fight against emerging hospital-borne infections, safeguarding patients in the places where they're most vulnerable.

Aging demographics and a spike in chronic conditions amongst Canadians combined with increased turnover of hospital rooms has forced healthcare providers to re-think their strategies for protecting patients at their most critical moments.

The threat is real. More than 200,000 patients get infections every year while receiving healthcare in Canada and more than 8,000 of these patients die as a result, according to a 2013 report from Canada's chief public health officer1.

To protect patients, hospitals have had to bolster their infection control teams and collaboration between infection prevention and environmental services as well as critical staff.

"There's been a greater effort to detect these bugs," explains Barley Chironda MSc, RPN, CIC Healthcare National Sales Director and Infection Control Specialist at Clorox Healthcare Canada. "What hospitals have realized is when there's a strong relationship between the infection prevention control and environmental services teams, then you actually have better compliance and reduced infection rates ? so that collaboration between those two stakeholders is significant."

To keep pace with the healthcare industry's evolving needs, Clorox Healthcare Canada has bolstered its own research surrounding microbiology, sporicidal agents and infection prevention. The result is a stream of innovative new products specifically for the hospital environment including Clorox Healthcare® Hydrogen Peroxide Cleaner Disinfectant Wipes, Clorox Healthcare® Bleach Germidical Wipes and Clorox Healthcare® Fusiontm Cleaner Disinfectant, a next-generation bleach product combining disinfecting efficacy against pathogens with broad surface compatibility.

The suite of ready-to-use facility-wide disinfectants for healthcare professionals tackle emerging pathogens like Clostridium difficile (C. difficile) spores, a bacterium causing serious illness in Canadian hospitals.

"One of the reasons C. difficile spreads so much is it creates that hard spore shell, making it extremely challenging to kill," says Chironda. "What we've been able to do at Clorox Healthcare is combine the technology of the bleach in the form of a wipe, making it a simple and efficient cleaning process."

Clorox Healthcare Canada offers a robust portfolio of surface cleaner-disinfectants, in addition to UV technology, to provide healthcare facilities with a comprehensive approach to environmental hygiene in efforts to prevent hospital-borne infections. Long trusted as a leader in disinfectant efficacy, Clorox Healthcare Canada also understands the challenges facilities face in balancing the need to prevent infections while protecting surfaces and costly equipment from damage.

Where sensitive surfaces require non-bleach solutions, Clorox Healthcaretm Hydrogen Peroxide Cleaner Disinfectant Wipes is a bleach alternative that kills 38 pathogens in one minute or less. The Clorox Healthcaretm Professional Disinfecting Bleach Wipes wipes provide broad-spectrum antimicrobial efficacy, able to combat 46 pathogens with kill times of one minute and effective against C. difficile spores in three minutes.

"C. difficile is the most critical pathogen facing healthcare, tomorrow it could be Ebola, the day after that it could be SARS, over the last couple of years we've had so many emerging threats," says Chironda. "For years Clorox Healthcare Canada has led the field with disinfectants that healthcare facilities trust for their broad efficacy, fast kill times and ease of use. So when emerging pathogens come through the doors, hospitals are even more prepared."

Visit www.cloroxprofessional.ca for more information.


1 https://www.canada.ca/en/public-health/corporate/publications/chief-public-health-officer-reports-state-public-health-canada/chief-public-health-officer-report-on-state-public-health-canada-2013-infectious-disease-never-ending-threat/healthcare-associated-infections-due-diligence.html (Accessed August 13, 2017)


SOURCE Clorox Healthcare Canada

These press releases may also interest you

at 10:07
In response to the Ebola outbreak that claimed more than 10,000 lives in West Africa four years ago, Canada and China worked on a new Ebola vaccine. Created by the Chinese Academy of Military Medical Sciences' Bioengineering Institute and CanSino...

19 mar 2018
NanoViricides, Inc. (the "Company") has announced that it has expanded its in vivo testing agreement with the University of Wisconsin to encompass testing its topical anti-herpes agents in animal models of HSV-induced dermal, ocular and genital...

15 mar 2018
"Little x Little," a global movement led by Generation Z to fix the future, officially launched today, setting an audacious goal of inspiring 2 billion acts of good by 2030 in support of the United Nations' Sustainable Development Goals. To...

14 mar 2018
The global Wound Healing market was valued at approximately US$ 23.3 Bn in 2016 is projected to register cumulative annual growth rate (CAGR) of over 4.8% from 2017 to 2025, according to a new report published by Transparency Market Research titled...

12 mar 2018
The "Global Viral Partnering 2012-2018: Deal trends, players and financials" report has been added to ResearchAndMarkets.com's offering. Global Viral Partnering 2012 to 2018 provides the full collection of Viral disease deals signed between the...

8 mar 2018
Notice is given to the Shareholders of Essity Aktiebolag (publ) ("Essity") of the Annual General Meeting of Shareholders to be held on Thursday 12 April 2018, at 3 p.m.at Stockholm Waterfront Congress Centre, Nils Ericsons Plan 4, Stockholm...

News published on 28 february 2018 at 06:00 and distributed by: